Effects of proteolytic degradation products of human fibrinogen and of human factor VIII on platelet aggregation and vascular permeability.
D000818:Animals; D012103:Batroxobin / Q000494:pharmacology; D002199:Capillary Permeability; D004305:Dose-Response Relationship, Drug; D005169:Factor VIII / Q000378:metabolism*; D005337:Fibrin; D005338:Fibrin Fibrinogen Degradation Products / Q000494:pharmacology*; D006801:Humans; D008970:Molecular Weight; D010455:Peptides; D010974:Platelet Aggregation; D051381:Rats; D013917:Thrombin / Q000494:pharmacology
D005338:Fibrin Fibrinogen Degradation Products; D010455:Peptides; D005169:Factor VIII; D005337:Fibrin; D012103:Batroxobin; D013917:Thrombin